Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 812

1.

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

Faraone SV, Glatt SJ.

J Clin Psychiatry. 2010 Jun;71(6):754-63. doi: 10.4088/JCP.08m04902pur.

PMID:
20051220
2.

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis.

Faraone SV, Buitelaar J.

Eur Child Adolesc Psychiatry. 2010 Apr;19(4):353-64. doi: 10.1007/s00787-009-0054-3.

PMID:
19763664
4.

Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.

Christensen L, Sasané R, Hodgkins P, Harley C, Tetali S.

Curr Med Res Opin. 2010 Apr;26(4):977-89. doi: 10.1185/03007991003673617.

PMID:
20178404
5.

[Pharmacotherapy of adult Attention Deficit/Hyperactivity Disorder (ADHD): a systematic review].

Mészáros A, Czobor P, Bálint S, Simon V, Bitter I.

Psychiatr Hung. 2007;22(4):259-70. Hungarian.

PMID:
18167421
7.
8.

Comparing the efficacy of medications for ADHD using meta-analysis.

Faraone SV, Biederman J, Spencer TJ, Aleardi M.

MedGenMed. 2006 Oct 5;8(4):4.

9.

Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.

Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, Moore H.

J Clin Psychiatry. 2005 Feb;66(2):253-9.

PMID:
15705013
10.

Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.

Biederman J, Pliszka SR.

J Pediatr. 2008 Mar;152(3):394-9. doi: 10.1016/j.jpeds.2007.07.052.

PMID:
18280848
11.

A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.

Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA; Modafinil ADHD Study Group..

J Clin Psychiatry. 2006 May;67(5):727-35.

PMID:
16841622
12.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
13.

Novel treatments for attention-deficit/hyperactivity disorder in children.

Spencer TJ, Biederman J, Wilens TE, Faraone SV.

J Clin Psychiatry. 2002;63 Suppl 12:16-22. Review.

14.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
16.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
17.

Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.

Verbeeck W, Tuinier S, Bekkering GE.

Adv Ther. 2009 Feb;26(2):170-84. doi: 10.1007/s12325-009-0008-7. Review.

PMID:
19238340
18.
19.
20.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
Items per page

Supplemental Content

Support Center